Juxtapid Capsule
Product Images NDC 76431-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Juxtapid (NDC 76431-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amryt Pharmaceuticals Dac, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Juxtapid 01)

FDA Label Image

Figure 1 (Juxtapid 02)

Figure 1 (Juxtapid 02)
This text appears to be a chart displaying the mean dose and reductions in LDL-C from Baseline over a 26 week period. The mean doses are listed as 5mg, 10mg, 18mg, 33mg, 40mg, and 43mg. The chart also includes a line graph showing the reductions in LDL-C from Baseline over time. However, it is difficult to fully interpret the chart without additional context or information.*
FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

Principal Display Panel (5 mg Capsule Bottle Label)
Juxtapid is a medication that comes in the form of capsules containing 5mg of lomitapide. The capsules should be kept out of reach of children, stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (between 59°F and 86°F). It is important to keep the capsules tightly closed and protected from moisture. Juxtapid is manufactured by Amryt Pharmaceuticals DAC in Dublin, Ireland. The medication is available in a 28 capsule pack, and it should only be dispensed with an accompanying medication guide. The dosage and use instructions can be found in the package insert, and Juxtapid is only available via prescription.*
FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Carton)

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Principal Display Panel (10 mg Capsule Bottle Label)
Juxtapid is a medication that comes in capsule form with each capsule containing 10mg of lomitapide. The medication should be kept out of the reach of children and stored at temperatures between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C and 30°C (between 59°F and 86°F). It should also be tightly closed and protected from moisture. The medication is manufactured for Amryt Pharmaceuticals DAC in Dublin, Ireland. Juxtapid is available in a package of 28 capsules and requires a prescription. For dosage and use instructions, please refer to the package insert, and each patient should be given an accompanying Medication Guide.*
FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Carton)

Principal Display Panel (10 mg Capsule Bottle Carton)
This is a medication description for Juxtapid capsules containing the active ingredient itapide, with each capsule having 10mg. The recommended temperature for storage is between 15°C and 0°C. The medication guide should be given to each patient, and the container must be kept tightly closed and protected from moisture, out of reach of children. The product is available in 10 mg, and the package contains 70014936.*
FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

Principal Display Panel (20 mg Capsule Bottle Label)
Juxtapid is a medication that comes in a capsule form with each capsule containing 20mg of lomitapide. It should be stored between 20°C to 25°C but excursions are permitted between 15°C to 30°C. The medication should be kept out of reach of children, should be tightly closed, and protected from moisture. Amryt Pharmaceuticals DAC based in Dublin Ireland manufactured it with the PN number of 4005-12 and NDC number of 76431-120-01. The medication is available in 28 capsules, and it's a prescription-only drug. Dosage and usage information could be obtained from the package insert, and each patient should receive the accompanying medication guide.*
FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Carton)

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Principal Display Panel (30 mg Capsule Bottle Label)
Juxtapid is a drug that comes in a capsule form with 30 mg of Lomitapide in each capsule. It is important to keep the drug out of reach of children and to store it at a temperature between 20°C to 25°C with excursions permitted between 15°C and 30°C. The drug should be kept tightly closed and protected from moisture. Juxtapid is manufactured by Amryt Pharmaceuticals DAC in Ireland. The package insert provides dosage and usage instructions, and should be dispensed to each patient along with the drug. The text also includes product codes PN 4081-02 and NDC 76431-130-01.*
FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Carton)

Principal Display Panel (30 mg Capsule Bottle Carton)
This is a medication package containing Juxtapid capsules. Each capsule contains lomitapide as an active ingredient. The package has 28 capsules of 30mg each. The medication is manufactured by Amity Pharmaceuticals DAC in Dublin, Ireland. The medication must be stored between 15°C to 30°C and should be kept away from children. The container should be tightly closed and protected from moisture. The package also includes a medication guide for the patients.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.